These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21446173)

  • 21. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
    Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
    Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of antiviral activity of extracts obtained from basidial fungi against influenza viruses of different subtypes in experiments in vitro and in vivo].
    Kabanov AS; Kosogova TA; Shishkina LN; Tepliakova TV; Skarnovich MO; Mazurkova NA; Puchkova LI; Malkova EM; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):40-3. PubMed ID: 21449077
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
    Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
    J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
    Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
    Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice.
    Shimizu T; Hino A; Tsutsumi A; Park YK; Watanabe W; Kurokawa M
    Antivir Chem Chemother; 2008; 19(1):7-13. PubMed ID: 18610553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice.
    Takahashi E; Sawabuchi T; Kimoto T; Sakai S; Kido H
    J Dairy Sci; 2019 Nov; 102(11):9559-9569. PubMed ID: 31495632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Renaud C; Kuypers J; Englund JA
    J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1).
    Zarogiannis SG; Noah JW; Jurkuvenaite A; Steele C; Matalon S; Noah DL
    Life Sci; 2012 Mar; 90(11-12):440-5. PubMed ID: 22269828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.
    Hall RJ; Peacey MP; Ralston JC; Bocacao J; Ziki M; Gunn W; Quirk A; Huang QS
    Euro Surveill; 2009 Jul; 14(30):19282. PubMed ID: 19643060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice.
    Aeffner F; Bratasz A; Flaño E; Powell KA; Davis IC
    Am J Respir Cell Mol Biol; 2012 Oct; 47(4):543-51. PubMed ID: 22679275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2009 pandemic H1N1 influenza virus is more pathogenic in pregnant mice than seasonal H1N1 influenza virus.
    Kim HM; Kang YM; Song BM; Kim HS; Seo SH
    Viral Immunol; 2012 Oct; 25(5):402-10. PubMed ID: 22985287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.
    Tsai AW; McNeil CF; Leeman JR; Bennett HB; Nti-Addae K; Huang C; Germann UA; Byrn RA; Berlioz-Seux F; Rijnbrand R; Clark MP; Charifson PS; Jones SM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6007-16. PubMed ID: 26169418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
    Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
    Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive transmissibility and fitness of oseltamivirsensitive and resistant pandemic influenza H1N1 viruses in ferrets.
    Duan S; Boltz DA; Seiler P; Li J; Bragstad K; Nielsen LP; Webby RJ; Webster RG; Govorkova EA
    Influenza Other Respir Viruses; 2011 May; 5(Suppl 1):79-82. PubMed ID: 21751461
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
    Barnard DL; Wong MH; Bailey K; Day CW; Sidwell RW; Hickok SS; Hall TJ
    Antivir Chem Chemother; 2007; 18(3):125-32. PubMed ID: 17626596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulaton and attenuation of lethal influenza A virus infection by oral administration with KIOM-C.
    Kim EH; Pascua PN; Song MS; Baek YH; Kwon HI; Park SJ; Lim GJ; Kim SM; Decano A; Lee KJ; Cho WK; Ma JY; Choi YK
    Antiviral Res; 2013 Jun; 98(3):386-93. PubMed ID: 23588232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.